Balearic archipelago: Three islands, three beta-thalassemia population patterns

Clinical Genetics

Volumn 83, Issue 2, 2013, Pages 175-180

  Lopez Escribano H ^a   Parera, M M ^a   Guix, P ^a   Serra, J M ^a   Gutierrez, A ^a   Balsells, D ^b   Oliva Berini, E ^c   Castro, J A ^d   Ramon, M M ^d   Picornell, A ^d  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b HOSPITAL CAN MISSES   (Spain)

^c Hospital Mateu Orfila   (Spain)

^d UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

thal mutations; Balearic Islands; Beta thalassemia thal; CD39 (C>T); Haemoglobinopathies; IVS I 110 (G>A); Spain

Indexed keywords

ARTICLE; BALEARIC ISLANDS; BETA THALASSEMIA; CHILD; GENE FREQUENCY; GENE MUTATION; GENETIC DRIFT; GENETIC SELECTION; HETEROZYGOTE; HISTORY; HUMAN; ISLAND (GEOLOGICAL); MAJOR CLINICAL STUDY; MALARIA; MEDITERRANEAN SEA; MOLECULAR EVOLUTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SPAIN;

BETA-GLOBINS; BETA-THALASSEMIA; GENETIC DRIFT; GENETIC TESTING; GENETICS, POPULATION; GENOTYPE; HETEROZYGOTE; HUMANS; ISLANDS; MUTATION; POINT MUTATION; REPRODUCTIVE ISOLATION; SPAIN;

EID: 84872041947     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2012.01864.x     Document Type: Article

References (27)

1. Cao A, Galanello R. Beta-thalassemia. Genet Med 2010: 12 (2): 61-76.
2. Rund D, Fucharoen S. Genetic modifiers in hemoglobinopathies. Curr Mol Med 2008: 8 (7): 600-608.
3. Pereira Mdel M, Dalmau AC, Corrons JL. Molecular heterogeneity of beta-thalassemia alleles in Spain and its importance in the diagnosis and prevention of beta-thalassemia major and sickle cell disorders. Hemoglobin 2009: 33 (3): 226-234.
4. Moreno-Miralles I, Bolufert-Gilabert P, Pérez-Sirvent M. The molecular changes in thalassemias in Spain. A review of existing studies. Med Clin (Barc) 1999: 113 (20): 789-794.
5. Tomàs C, Jiménez G, Picornell A, Castro JA, Ramon MM. Differential maternal and paternal contributions to the genetic pool of Ibiza Island, Balearic Archipelago. Am J Phys Anthropol 2006: 129 (2): 268-278.
6. Guix P, Picornell A, Parera M et al. Distribution of HFE C282Y and H63D mutations in the Balearic Islands (NE Spain). Clin Genet 2002: 61 (1): 43-48.
7. Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest 2007: 67 (1): 71-86.
8. Moreno I, Bolufer P, Perez ML, Barragán E, Sanz MA. Rapid detection of the major Mediterranean beta-thalassaemia mutations by real-time polymerase chain reaction using fluorophore-labelled hybridization probes. Br J Haematol 2002: 119 (2): 554-557.
9. Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol 2004: 26 (3): 159-176.
10. Vives-Corrons JL, Pujades MA, Miguel-García A, Miguel-Sosa A, Cambiazzo S. Rapid detection of Spanish (delta beta) zero-thalassemia deletion by polymerase chain reaction. Blood 1992: 80 (6): 1582-1585.
11. Modell B, Darlison M, Birgens H et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest 2007: 67 (1): 39-69.
12. Tegos CN, Voutsadakis AJ, Karmas PA. Diagnostic strategy for thalassemias and other hemoglobinopathies: a program applied to the Hellenic Army recruits. Mil Med 1992: 157 (4): 183-185.
13. Haj Khelil A, Denden S, Leban N et al. Hemoglobinopathies in North Africa: a review. Hemoglobin 2010: 34 (1): 1-23.
14. Hedrick PW. Population genetics of malaria resistance in humans. Heredity 2011: 107 (4): 283-304.
15. Oliva Berini E, Cladera Serra A, Torrent Quetglas M. Campaign for detection of minor beta-thalassemia and prevention of major beta-thalassemia in the isle of Menorca: 10-year experience. Med Clin (Barc) 1998: 110 (10): 361-364.
16. Muñoz M. Estudio biodemográfico de la supervivencia humana en población menorquina. PhD Thesis, Universidad de Barcelona, Spain, 1997.
17. Moral P. Estudio antropogenético de diversos polimorfismos en la isla de Menorca. PhD Thesis, Universidad de Barcelona, Spain, 1987.
18. Cladera Serra A, Oliva Berini E, Torrent Quetglas M, Bartolozzi Castilla E. Prevalence of glucose-6-phosphate dehydrogenase deficiency in a student population on the island of Menorca. Sangre (Barc) 1997: 42 (5): 363-367.
19. Rosatelli MC, Dozy A, Faà V, Meloni A, Sardu R, Saba L. Molecular characterization of beta-thalassemia in Sardinian population. Am J Hum Genet 1992: 50 (2): 422-426.
20. Chehab FF, Der Kaloustian V, Khouri FP, Deeb SS, Kan YW. The molecular basis of beta-thalassemia in Lebanon: application to prenatal diagnosis. Blood 1987: 69 (4): 1141-1145.
21. Zahed L. The spectrum of beta-thalassemia mutations in the Arab populations. J Biomed Biotechnol 2001: 1 (3): 129-132.
22. Macabich I. Historia de Ibiza, Vol. I. Palma de Mallorca: Daedalus, 1966.
23. Chouk I, Daoud BB, Mellouli F et al. Contribution to the description of the beta-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin 2004: 28 (3): 189-195.
24. Efremov GD. Thalassemias and other hemoglobinopathies in the Republic of Macedonia. Hemoglobin 2007: 31 (1): 1-15.
25. Pavlovic S, Urosevic J, Poznanic J et al. Molecular basis of thalassemia syndromes in Serbia and Montenegro. Acta Haematol 2005: 113 (3): 175-180.
26. Faustino P, Osório-Almeida L, Barbot J et al. Novel promoter and splice junction defects add to the genetic, clinical or geographic heterogeneity of beta-thalassaemia in the Portugese population. Hum Genet 1992: 89 (5): 573-576.
27. Petkov GH, Efremov GD. Molecular basis of beta-thalassemia and other hemoglobinopathies in Bulgaria: an update. Hemoglobin 2007: 31 (2): 225-232.